Alterations in the pulmonary function tests of inflammatory bowel diseases

dc.authoridHacievliyagil, Suleyman Savas/0000-0002-2572-1870
dc.authoridyalniz, mehmet/0000-0001-7776-4154
dc.authoridKarincaoglu, Melih/0000-0002-9727-5128
dc.authorwosidHacievliyagil, Suleyman Savas/ABI-7307-2020
dc.authorwosidSeckin, Yuksel/ABI-3468-2020
dc.authorwosidyalniz, mehmet/G-6767-2015
dc.contributor.authorAtes, Fehmi
dc.contributor.authorKarincaoglu, Melih
dc.contributor.authorHacievliyagil, Suleyman Savas
dc.contributor.authorYalniz, Mehmet
dc.contributor.authorSeckin, Yuksel
dc.date.accessioned2024-08-04T21:02:25Z
dc.date.available2024-08-04T21:02:25Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground/aims: We aimed to determine the changes in the pulmonary function tests of the patients with inflammatory bowel diseases. Methods: Forty inflammatory bowel dieases patients; 30 ulcerative colitis and 10 Crohn's disease, and age- and sex-matched control group, consisting of 30 healthy persons, were included in the study. Disease activity in patients with ulcerative colitis was assessed by Truelove and Witts Criteria and in Crohn's disease patients by Chron's Disease Activity Index. Results: Pulmonary function tests were found abnormal at least in. one parameter in, 17 / 30 ulcerative colitis patients (56%) and in 5/10 Crohn's disease patients (50%) in the activation period and in 5/30 ulcerative colitis patients (17%) and in 2/10 Crohn's disease patients (20%) in the remission period of the diseases of the same patients. Forced vital capacity, first second, residual volume 1 total lung capacity, diffusing capacity of the lung for carbon monoxide and diffusing capacity of the lung for carbon monoxide per liter alveolar volume values were found significantly impaired in the activation period in comparison with the values of the same patients in the remission period (p<0.01). It was found that pulmonary function test values in patients with inflammatory bowel dieases were not affected by either the type of disease or treatment with 5-aminosalicylic acid. However, they were affected notably by the disease activity. Conclusion: Pulmonary function test abormalities were found frequently in patients with inflammatory bowel dieases without presence of any respiratory symptoms and lung radiograph findings. The severity and frequency of these pulmonary function test abnormalities which were detected even in the remission periods increase with the activation of the disease. Therefore, pulmonary function test may be used as a non-invasive diagnostic procedure in determining the activation of inflammatory bowel dieases and might aid to the early diagnosis of the latent respiratoryen_US
dc.identifier.doi10.4318/tjg.2011.0215
dc.identifier.endpage299en_US
dc.identifier.issn1300-4948
dc.identifier.issn2148-5607
dc.identifier.issue3en_US
dc.identifier.pmid21805420en_US
dc.identifier.scopus2-s2.0-79961109935en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage293en_US
dc.identifier.trdizinid125353en_US
dc.identifier.urihttps://doi.org/10.4318/tjg.2011.0215
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/125353
dc.identifier.urihttps://hdl.handle.net/11616/104741
dc.identifier.volume22en_US
dc.identifier.wosWOS:000293434100009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInflammatory bowel diseasesen_US
dc.subjectpulmonary function testsen_US
dc.subjectcarbon monoxide diffusion testen_US
dc.titleAlterations in the pulmonary function tests of inflammatory bowel diseasesen_US
dc.typeArticleen_US

Dosyalar